This study evaluates whether the addition of immune therapy to usual FOLFOX chemotherapy in patients with deficient DNA mismatch repair stage III colon cancer can improve your outcome compared to FOLFOX alone. The immune therapy drug, atezolizumab, may allow your body's immune system to more effectively kill…
The Mailman School of Public Health at Columbia University is doing a research study to learn how to best improve sleep health in couples for supporting heart health. We are looking for couples aged 30-65 years with no history of cancer or heart disease. To see if individuals qualify for the study, couples who are interested…
The Mailman School of Public Health at Columbia University is doing a research study to learn how improving sleep habits affects heart health. We are looking for adults aged 30+ years with no history of cancer or heart disease. To see if individuals qualify for the study, those who are interested in participating will first do…
This research study is sponsored by ImmunogenX and The National Institutes of Health (NIH, Bethesda, MD). The objective of this study is to determine if the investigational product (latiglutenase) will help decrease symptoms in subjects with celiac disease while maintaining a gluten-free diet while undergoing periodic gluten exposure. In addition, this…